Integration of at-home EEG sleep monitoring into decentralized clinical trials enables objective measurement of sleep architecture with 88-96% agreement to laboratory polysomnography. This addresses a critical measurement gap in CNS studies where sleep quality directly influences neurological outcomes and therapeutic response.
Key Points
- At-home EEG captures sleep stages with 88-96% polysomnography agreement
- Decentralized measurement reduces trial burden while maintaining diagnostic rigor
- Sleep staging integrated with cognition, mood, and speech biomarkers
Longevity Analysis
Sleep quality determines the efficacy of nearly every intervention targeting neurological health and cognitive decline. Reliable, home-based measurement transforms how researchers can assess this foundational process without forcing participants into sleep laboratories—where the artificial environment itself degrades sleep quality and produces misleading data. By combining objective sleep architecture with simultaneous measurement of cognitive function, mood state, and neural activity, this platform creates a more complete picture of how central nervous system function responds to interventions. For individuals managing neurological health across the lifespan, the ability to track sleep stage distribution, slow-wave content, and sleep spindles outside the clinic establishes a practical method for identifying when sleep disruption precedes or accompanies cognitive decline.
Original published by Longevity.Technology.